VRNA logo

Verona Pharma (VRNA) Shareholders Equity

Annual Shareholders Equity

$249.28 M
+$18.82 M+8.16%

31 December 2023

VRNA Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$130.49 M
-$37.78 M-22.45%

30 September 2024

VRNA Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VRNA Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.2%-50.5%
3 y3 years+34.9%-22.4%
5 y5 years+209.8%+163.5%

VRNA Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+68.4%-52.9%+17.7%
5 y5 yearsat high+483.2%-52.9%+452.4%
alltimeall timeat high>+9999.0%-52.9%+7808.1%

Verona Pharma Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$130.49 M(-22.5%)
June 2024
-
$168.27 M(-25.2%)
Mar 2024
-
$224.99 M(-9.7%)
Dec 2023
$249.28 M(+8.2%)
$249.28 M(-5.4%)
Sept 2023
-
$263.53 M(-3.5%)
June 2023
-
$273.09 M(-1.3%)
Mar 2023
-
$276.75 M(+20.1%)
Dec 2022
$230.47 M(+55.7%)
$230.47 M(-3.0%)
Sept 2022
-
$237.49 M(+114.2%)
June 2022
-
$110.88 M(-12.2%)
Mar 2022
-
$126.31 M(-14.7%)
Dec 2021
$148.00 M(-19.9%)
$148.00 M(-12.0%)
Sept 2021
-
$168.20 M(+8.9%)
June 2021
-
$154.40 M(-10.4%)
Mar 2021
-
$172.41 M(-6.7%)
Dec 2020
$184.85 M(+332.5%)
$184.85 M(-6.5%)
Sept 2020
-
$197.72 M(+736.9%)
June 2020
-
$23.62 M(-26.0%)
Mar 2020
-
$31.94 M(-25.3%)
Dec 2019
$42.74 M(-46.9%)
$42.74 M(-13.7%)
Sept 2019
-
$49.52 M(-21.6%)
June 2019
-
$63.14 M(-16.7%)
Mar 2019
-
$75.80 M(-5.8%)
Dec 2018
$80.47 M(-25.5%)
$80.47 M(-5.3%)
Sept 2018
-
$84.95 M(-2.7%)
June 2018
-
$87.35 M(-5.1%)
Mar 2018
-
$92.01 M(-14.8%)
DateAnnualQuarterly
Dec 2017
$107.95 M(+153.8%)
$107.95 M(-5.4%)
Sept 2017
-
$114.17 M(-5.8%)
June 2017
-
$121.23 M(+185.1%)
Dec 2016
$42.53 M(+428.3%)
$42.53 M(+664.6%)
June 2016
-
$5.56 M(-30.9%)
Dec 2015
$8.05 M(-59.0%)
$8.05 M(-44.2%)
June 2015
-
$14.43 M(-26.5%)
Dec 2014
$19.62 M(+475.3%)
$19.62 M(-16.9%)
June 2014
-
$23.60 M(+592.2%)
Dec 2013
$3.41 M(-18.9%)
$3.41 M(-14.6%)
June 2013
-
$3.99 M(-5.1%)
Dec 2012
$4.21 M(-33.1%)
$4.21 M(-33.6%)
June 2012
-
$6.34 M(+0.7%)
Dec 2011
$6.29 M(+18.1%)
$6.29 M(+48.3%)
June 2011
-
$4.24 M(-20.4%)
Dec 2010
$5.33 M(-26.5%)
$5.33 M(-21.3%)
June 2010
-
$6.76 M(-6.7%)
Dec 2009
$7.25 M(+23.9%)
$7.25 M(+36.2%)
June 2009
-
$5.32 M(-9.0%)
Dec 2008
$5.85 M(+2.1%)
$5.85 M(-35.0%)
June 2008
-
$9.00 M(+57.1%)
Dec 2007
$5.73 M(-25.0%)
$5.73 M(-17.1%)
June 2007
-
$6.91 M(-9.5%)
Dec 2006
$7.64 M(+353.3%)
$7.64 M(+362.8%)
June 2006
-
$1.65 M(-2.0%)
Dec 2005
$1.68 M
$1.68 M(-5.6%)
June 2005
-
$1.78 M

FAQ

  • What is Verona Pharma annual stockholders equity?
  • What is the all time high annual shareholders equity for Verona Pharma?
  • What is Verona Pharma annual shareholders equity year-on-year change?
  • What is Verona Pharma quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Verona Pharma?
  • What is Verona Pharma quarterly shareholders equity year-on-year change?

What is Verona Pharma annual stockholders equity?

The current annual shareholders equity of VRNA is $249.28 M

What is the all time high annual shareholders equity for Verona Pharma?

Verona Pharma all-time high annual stockholders equity is $249.28 M

What is Verona Pharma annual shareholders equity year-on-year change?

Over the past year, VRNA annual stockholders equity has changed by +$18.82 M (+8.16%)

What is Verona Pharma quarterly stockholders equity?

The current quarterly shareholders equity of VRNA is $130.49 M

What is the all time high quarterly shareholders equity for Verona Pharma?

Verona Pharma all-time high quarterly stockholders equity is $276.75 M

What is Verona Pharma quarterly shareholders equity year-on-year change?

Over the past year, VRNA quarterly stockholders equity has changed by -$133.04 M (-50.48%)